Resolution of Gastroparesis Symptoms With the Removal of a Dipeptidyl Peptidase-4 Inhibitor

被引：0
|
作者：
Nuvvula, Sri [1 ]
Rau, Prashanth [2 ]
Belkin, Dimitri [2 ]
Houghton, Jean Marie [1 ]
机构：
[1] Univ Massachusetts, Med Sch, Worcester, MA USA
[2] Univ Massachusetts, Med Ctr, Worcester, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S3125
引用
收藏
页码：S1289 / S1289
页数：1
相关论文
共 50 条
  • [41] Stereoselective Synthesis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, (R)-Sitagliptin
    Anjibabu, Ramisetti
    Boggu, Jagan Mohan Reddy
    Shekhar, Putta
    Reddy, Basi V. Subba
    CHEMISTRYSELECT, 2016, 1 (17): : 5445 - 5447
  • [42] The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
    Kanasaki, Keizo
    CLINICAL SCIENCE, 2018, 132 (04) : 489 - 507
  • [43] Development of a Scalable Synthesis of Dipeptidyl Peptidase-4 Inhibitor ABT-279
    McDermott, Todd S.
    Bhagavatula, Lakshmi
    Borchardt, Thomas B.
    Engstrom, Kenneth M.
    Gandarilla, Jorge
    Kotecki, Brian J.
    Kruger, Albert W.
    Rozema, Michael J.
    Sheikh, Ahmad Y.
    Wagaw, Seble H.
    Wittenberger, Steven J.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (06) : 1145 - 1155
  • [44] Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
    Dave, Darshan J.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 230 - 235
  • [45] Clinical markers associated with glycaemic response to dipeptidyl peptidase-4 inhibitor therapy
    Yamagishi, Sho-ichi
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (07)
  • [46] Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?
    Lee, Yong-ho
    DIABETES & METABOLISM JOURNAL, 2015, 39 (03) : 204 - 206
  • [47] Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction?
    Scott, Susanne I.
    Andersen, Michelle F.
    Aagaard, Lise
    von Buchwald, Christian
    Rasmussen, Eva R.
    CURRENT DIABETES REVIEWS, 2018, 14 (04) : 327 - 333
  • [48] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Deacon, Carolyn F.
    Holst, Jens J.
    ADVANCES IN THERAPY, 2009, 26 (05) : 488 - 499
  • [49] DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity
    Yeh, Kai-Chia
    Yeh, Teng-Kuang
    Huang, Chung-Yu
    Hu, Chih-Bo
    Wang, Min-Hsien
    Huang, Yu-Wen
    Chou, Ling-Hui
    Ho, Hsuan-Hui
    Song, Jen-Shin
    Hsu, Tsu
    Jiaang, Weir-Torn
    Chao, Yu-Sheng
    Chen, Chiung-Tong
    LIFE SCIENCES, 2021, 278
  • [50] Linagliptin: The Newest Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Aletti, Rachael
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2012, 20 (01) : 45 - 51
12345